Ledger.Open graph →
SEC Form D · Amendment · filed March 29, 2019

Rodeo Therapeutics Corp

Offering
$7.9M
Sold
$7.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Estaban Posada Martinez · SEATTLE, WADirectorKatie Hewitt · Seattle, WADirectorIan Howes · Seattle, WAExecNicole Ramroop · Grand Cayman, Cayman IslandsDirectorTadataka Yamada · Seattle, WADirectorChuck Stonecipher · SEATTLE, WADirectorLarry Thornton · Sioux Falls, SDExec · Director · PromoterGanapathy Sundaram · New York, NYExecThong Le · Seattle, WAExec · Director · PromoterSanford Markowitz · Seattle, WADirectorSuzanne Rettenmier · Seattle, WAExecJacob (Kobi) R. Vortman, Phd · Tirat Carmel, L3Exec · Director · PromoterJian Y. Gao · Hong Kong, Hong KongDirectorFrederic H. Moll · Tirat Carmel, L3DirectorRiyaz Nooruddin · Grand Cayman, Cayman IslandsExecEyal R. Zadicario, Phd · Tirat Carmel, L3DirectorJoel Marcus · Seattle, WADirectorMike Lee · San Francisco, CADirectorAsish Xavier · Seattle, WADirectorMichael Peck · Leawood, KSExecKendall Mohler · Seattle, WAExecTadataka Yamada · Seattle, WADirectorSteven Spencer · New York, NYDirectorMargarita Chavez · Seattle, WADirectorMichael H. Stansky · Tirat Carmel, L3DirectorJosuhe Leonardo Estrada Alanis · SEATTLE, WADirectorJinzhi Jiang · Hong Kong, Hong KongExecFrancisco Fabricio Mendoza Ramirez · SEATTLE, WADirectorJoel H. Norton · Tirat Carmel, L3DirectorSteve Gillis · Seattle, WADirectorIan Howes · Seattle, WAExecArjun (Jj) H. Desai, Md · Tirat Carmel, L3DirectorJaclyn B. Lautz · Newport News, VAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗